I agree in the potential of the product ReCell , but not the capital management approach, not loading up the company with huge overhead and then trying to fill it with agency line, not with shifting focus to somebody else’s product where we have a limited contractual period and accept a sub par for medical devices margin. I have decided to sit pretty much on the sidelines with only 25% of my original investment and sold the rest until there is some targets hit and positive cash. DYOR and for the sake of patients I hope this turns around.
AVH Price at posting:
$1.67 Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)